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INTRODUCTION 
The nephrolithiasis is the most frequent urological disease.1•2 The stone 
incidence in general is 1-4°/o and can be compared with that of diabetes 
mellitus. 
Hedenberg called attention to the fact that the published data represent 
pure hospital statistics and don't include the 70_.:.__800/o of stone patients which 
were not sent to a hospital. Ljunghall and Hedstrand3 estimated the real 
percentage of stone.:formers iri th.e general population to be much higher 
(13. 70/o). 
An additional problem is the high stone-recurrence-rate. Folfowing Alken 
and Herrmann4 respectively Kollwitz et al.,5 this recurrence rate is 50°/o. 
Ljunghall and Hedstrand3 calculated even a 720/o probability of stone recur-
rence in absence of any metaphylactic precautions. 
In the last years, the stone-incidence is increasing. Schneider2 speaks of 
a weavy course of the stone-incidence: the stone-frequency increased after 
1927, dropped fo a fifth duririg and after the world war II arid rised steeply 
since 1948. The increased stone-frequency seems to be -related to the raised 
living standard, social state, increased protein consumption as well as to the 
raised serum uric acid level. 
The high actuality of the prevention and dissolution of urinary stones is 
obvious. Nowadays only the uric acid calculi and to some extent _ the cystine 
calculi, representing 15 to 250/o of all calculi, can be dissolved perorally. The 
residual 75 to 85'0/o of renal stones, being composed of Ca-oxalate and phosphate, 
are not accessible to the peroral chemolitholysis. 
Using a new quantitative measuring technique, based · on the Coulter 
princip!e, we were __ able to test in vitro about 8~ substances with respect to 
their inhibitory and crystal dissolving properties. 
* Based on an invited lecture presented at the 5th »Ruder Boskovic« Insti-
tute's International Summer Conference Chemistry of Solid/Liquid Interfaces, Cav-
tat/Dubrovnik, Croatia, Yugoslavia, June 1979. 
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Here, only the tricarboxylic acids of the Krebs-cycle, the citric, the aconitic 
and the isocitric acid as well as the structurally similar tricarballylic acid will 
be presented. 
METHODS 
Meta- and instable Ca-oxalate solutions as well as suspensions of oxalate and 
phosphate crystals were treated for 48 hours with test substances of a definite con-
centration and the size distribution of crystals both in the test and in the reference 
suspension was evaluated quantitatively by Coulter Counter and Cha11nelyzer. Here, 
the results can be presented only in a very simplified manner as numbers respectively 
volumes of crystals in the particular size classes. The efficacy of the tested sub-
stances can be deduced directly from the reduction of crystal number and crystal 
volume after the incubation with the test substance. 
In schedules to be presented, the crystal number in the reference suspension 
is designated by nblank• the corresponding volume by Vblank· The crystal number in 
the test solution after the 48-hour-incubation was denoted (signified) by nsample and 
the corresponding crystal volume by Vsample· 
Sbig represents the sum of big crystals and Stat the sum of all crystals measured. 
RESULTS 
In Figure 1, the crystal growth-inhibition from an oversaturated Ca-
-oxalate solution in presence of aconitate is demonstrated. The lower values 
Eor nsample compared with those for nblank indicate the inhibited respectively 
the prevented precipitation and growth of oxalate crystals by aconitate. The 
:iconitate proved to be efficaceous not only in the inhibition of precipitation 
but also in the dissolution of preformed Ca-oxalate crystals (Figure 2). 
INHIBITED GROWTH OF CA-OXALATE CRYSTALS .IN. THE PRESENCE 
OF CIS-ACONITATE 
d(um) nblank nsarnple 
8,4 - 10,6 4854 
.:!: 380 4336 + 340 
10,6 - 12,1 4028 .:!: 316 3614 
.:!: 308 
12,1 - 13,3 3822 + 300 2788 ± 218 
13,3 - 14,3 3924 + 308 
14,3 - 15,2 3924 
.:!: 308 
15,2 - 16,0 3822 + 300 
16,0 - 16,8 3718 ± 292 
16,8 - 17,4 3512 + 276 
17,4 - 18, 1 3098 + 242 
sbig 25.820 2.788 
stet 34.702 10.738 
Figure 1. 
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DISSOLUTION OF STONE-FORMING CRYSTALS BY CIS - ACONITATE 
• ~a-oxalate cr:x:stals 
nblank nsarnple vb lank Vs ample 
sbig 16.732 11.671 25.504 16.457 
5tot 41.416 31.398 39.262 27.416 
• Hydroxylapatite cr:x:stals 
nblank nsarnple vb lank Vsample 
shiq 10.018 4.338 13.214 s.o58 
stot 28.712 14. 770 23.854 11.118 
Figure 2. 
DISSOLUTION OF STONE-FORMING CRYSTALS.BY D,I,-ISOCITRATE 
• Ca-oxalate cr:x:stals 
nsampl.e Vsample· 
16.732 4.441 25.504 5.328 
41 •. 416 15.802 39.262 1l.690 
• . Whewellite/weddellite cr:x:stals 
VsamJJle 
2.168 2.337 
12.636 2892 8.223 1.463 
Figure 3. 
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Again, a direct comparison of nblank and n,ample clearly shows the high 
efficacy of aconitate. 
Aconitate proved to dissolve not only the oxalate but also the phosphate 
crystals and disintegrated urinary stones (Figure 2). The difference between 
the number and size of crystals before and after incubation with aconitate is 
obvious. 
In Figure 3, the dissolution of oxalate crystals and of disintegrated oxalate 
stones (whewellite and weddellite) by isocitrate is demonstrated. Crystal number 
and volume are m arkedly reduced after treatment ]:)y the sodium salt of iso-
ci tric acid. . 
Isocitrate is also highly efficaceous in the dissolution of various kinds of 
phosphate crystals, as can be deduced from the lower values both of Sbig and 
8 101 in the test suspension, compared with the reference suspension (Figure 4). 
The high efficiency of sodium citrate in dissolution of artificial oxalate 
crystals and disintegrated oxalate stones is evident. Like other active sub-
stances, citrate is much more effective in inhibiting the precipitation and 
growth of crystals than in dissolution of existing crystals (Figure 5) . 
PARTI.AL DISSOLUTION .OF PHOSPHATE CRYSTALS BY D,L-ISOCITRATE 
• Drushite crystals 
nblank n sample vb lank vsample 
sbig 7.022 9.063 
5 tot 15.904 4.234 H.375 2.305 
• "' Hydroxyla12ati te ·cr:tstals 
nblank n . sample vblarik v sample 
5big 10·.018 13.214 
5tot 28.712 2.276 23.854 1. 113 
.• Struvite cr:tst~ls 
nblank ·· llsample vhlarik Vsample 
5big 7.748 10.069 
5 tot 18.904 16·. 591 
Figure 4. 
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PARTIAL DISSOLUTION OF STONE-FORMING CRYSTALS BY CITRATE 
• Ca-oxalate crystals 
sbig 16.732 





nblank n sample 
5big 2 .168 
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stot 28.712 3.614 
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INFLUENCE OF TRICARBALLYLATE ON NUCLEATION AND GROWTH OF 
CA-OXALATE CRYSTALS (IN PRESENCE OF CRYSTAL SEEDS) 
d(~m) nblank n seeds n sample 
8,4 - 10,6 14.046 ± 1102 1:756 ± 157 3.408 ± 368 
10,6 - 1 2' 1 12.394 ± 972 1.032 ± 92 2.478 ± 194 
12' 1 - 13,3 9. 192 ± 722 749 ± 67 516 ± 40 
13,3 - 14,3 6.300 ± 494 516 ± 46 
14,3 - 15,2 5.060 + 396 206 ± 18 
15, 2 
-
16,0 4.142 ± 324 
16,0 - 16,8 3.408 ± 268 
16' 8 - 17,4 2.996 ± 234 
17,4 - 18, 1 1.550 ± 120 
sbig 32.638 1. 4 71 516 
stot 59.078 4.259 6402 
Fig u re 7. 
PARTIAL DISSOLUTION OF STONE-FORMING CRYSTALS BY TRICARBALLYLATE 
Ca-oxalate crystals 
nblank n vhlank 
v 
sample sample 
8big 16.732 9.915 
25.504 13.517 
s .tot 41.416 26.647 39 . 262 22 . 901 
Brushite crystals 
nblank n vb lank 
v 
sample sample 
sbig 7 .022 3.512 9.063 
4 . 294 
stot 15.904 10.742 14.375 
8.525 
Figure 8. 
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DISSOLUTION OF PHOSPHATE CRYSTALS BY TRICARBALLYLATE 
H:tdrox:tlaeatite cr:tstals 
nblank nsample vb lank vsample 
sbig 10.018 2. 374 13.214 2.718 
stot 28. 712 11.360 23.854 7. 951 
Struvite cr:tstals 
nblank nsample vb lank ..,sample 
·Sbig 7.748 2.375 10.068 2.560 
5 tot 18.904 11. 154 16.591 7. 729 
Figure 9. 
In Figure 6, the dissolution of phosphate crystals and crystalline stone-
-material by citrate is demonstrated. 
The sodium tricarballylate presented in Figure 7, was of interest because 
of its structural similarity with the tricarboxylic acids described and because 
of its possible renal elimination in an unchanged, litholytically active form. 
Here, the influence of tricarballylate on growing oxalate crystals is demon-
strated. Again, the nsamp1e-values are distinctly lower than the n blank-values. 
In Figure 8, the dissolution of Ca-ox alate crystals in presence of sodium 
tricarballylate is shown. The reduced nsample-values indicate the partial dis-
solution of stone-forming crystals. 
Sodium tricarballylate proved to be efficaceous also in dissolving phosphate 
crystals, as can be concluded from the distinctly decreased crystal number in 
the test suspension in comparison to the reference solution (Figure 9). 
CONCLUSION 
From our experimental data, it can be concluded that all the tricarboxylic 
acids tested showed a clear inhibitory effect on growing oxalate crystals. There 
was also a distinct dissolution of oxalate and phosphate crystals as well as of 
the disintegrated renal calculi. 
This seems to be of special importance in connection with our observation 
of a significantly reduced citric .acid excretion in reccurrent stone-formers. 
In animal experiments, we were able to increase the urinary citric acid 
level 7.2 to 7.8 fold by malonate and 8 fold by equimolar mixture of oxal-
acetate and acetate. 
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SAZETAK 
Laboratorijski eksperimenti otapanja · bubreznih kamenaca kalcijeva oksalata 
kalcijeva fosfata u trikarboksilnim kiselinama Krebsova ciklusa. Rezultati 
istrazivanja i perspektive in vivo 
P. Leskovar, R. Hartung, R. Allgayer i A. Siebert 
Opisani su pokusi koji dokazuju da trikarboksilne kiseline Krebsova ciklusa 
inhibiraju rast oksalatnih kristala. Isto tako opazen je znatan utjecaj tih kiselina na 
otapanje i oksalatnih i fosfatnih kristala, kao i samih buqrefoih kamenaca. 
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